{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:02:18Z","timestamp":1782273738493,"version":"3.54.5"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10875-022-01359-6","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T01:02:21Z","timestamp":1661734941000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disseminated BCG Disease in a Patient with Hyper IgE Syndrome due to Dominant-Negative STAT3 Mutation\u2014Case Report"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-2957","authenticated-orcid":false,"given":"Luciano","family":"Urdinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Danielian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Oleastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Garrahan Hospital Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia H.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Lopez","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Izaguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"issue":"8","key":"1359_CR1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202592","volume":"218","author":"T Asano","year":"2021","unstructured":"Asano T, Khourieh J, Zhang P, et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 2021;218(8): e20202592. https:\/\/doi.org\/10.1084\/jem.20202592.","journal-title":"J Exp Med"},{"issue":"5","key":"1359_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","volume":"41","author":"C Tsilifis","year":"2021","unstructured":"Tsilifis C, Freeman AF, Gennery AR. STAT3 hyper-IgE syndrome-an update and unanswered questions. J Clin Immunol. 2021;41(5):864\u201380. https:\/\/doi.org\/10.1007\/s10875-021-01051-1.","journal-title":"J Clin Immunol"},{"key":"1359_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12941-022-00500-y","volume":"21","author":"SA Mahdaviani","year":"2022","unstructured":"Mahdaviani SA, Fallahi M, Jamee M, et al. Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian susceptibility to mycobacterial disease (MSMD): a case series. Ann Clin Microbiol Antimicrob. 2022;21:8. https:\/\/doi.org\/10.1186\/s12941-022-00500-y.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"30","key":"1359_CR4","doi-asserted-by":"publisher","first-page":"eaau6759","DOI":"10.1126\/sciimmunol.aau6759","volume":"3","author":"R Mart\u00ednez-Barricarte","year":"2018","unstructured":"Mart\u00ednez-Barricarte R, Markle JG, Ma CS, et al. Human IFN-\u03b3 immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3(30):eaau6759. https:\/\/doi.org\/10.1126\/sciimmunol.aau6759.","journal-title":"Sci Immunol."},{"key":"1359_CR5","doi-asserted-by":"publisher","unstructured":"Staels F, Lorenzetti F, De Keukeleere K, et al. A novel homozygous stop mutation in IL23R causes Mendelian susceptibility to mycobacterial disease [published online ahead of print, 2022 Jul 13]. J Clin Immunol. 2022. https:\/\/doi.org\/10.1007\/s10875-022-01320-7","DOI":"10.1007\/s10875-022-01320-7"},{"issue":"30","key":"1359_CR6","doi-asserted-by":"publisher","first-page":"eaau8714","DOI":"10.1126\/sciimmunol.aau8714","volume":"3","author":"S Boisson-Dupuis","year":"2018","unstructured":"Boisson-Dupuis S, Ramirez-Alejo N, Li Z, et al. Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3(30):eaau8714. https:\/\/doi.org\/10.1126\/sciimmunol.aau8714.","journal-title":"Sci Immunol."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01359-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T07:09:37Z","timestamp":1673680177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01359-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Patients or legal guardians have given written consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}